Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025… Read More
Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for… Read More
Committee Markup Advances Solutions to Crack Down on Big Pharma’s Patent… Read More
Big Pharma’s Arguments Against Bipartisan, Market-Based Solutions to Foster… Read More
Lawmakers Should Advance Biosimilar Red Tape Elimination Act, Medication… Read More
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. Ruling Will Help Protect… Read More
Lawmakers Should Advance the ETHIC Act and Skinny Labels, Big Savings Act to… Read More
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More